About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- Levonorgestrel/ethinylestradiol, ethinylestradiol (combination pack)
- Procedure number
- PSUSA/00010442/202001
- Regulatory outcome
- Variation
Documents
Levonorgestrel/ethinylestradiol, ethinylestradiol (combination pack): CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00010442/202001
English (EN) (235.48 KB - PDF)
български (BG) (237.09 KB - PDF)
español (ES) (181.51 KB - PDF)
čeština (CS) (214.41 KB - PDF)
dansk (DA) (193.75 KB - PDF)
Deutsch (DE) (215.2 KB - PDF)
eesti keel (ET) (193.81 KB - PDF)
ελληνικά (EL) (239.28 KB - PDF)
français (FR) (201.14 KB - PDF)
hrvatski (HR) (267.42 KB - PDF)
italiano (IT) (200.26 KB - PDF)
latviešu valoda (LV) (248.32 KB - PDF)
lietuvių kalba (LT) (256.13 KB - PDF)
magyar (HU) (270.61 KB - PDF)
Malti (MT) (301.16 KB - PDF)
Nederlands (NL) (184.57 KB - PDF)
polski (PL) (248.24 KB - PDF)
português (PT) (198.75 KB - PDF)
română (RO) (253.09 KB - PDF)
slovenčina (SK) (193.08 KB - PDF)
slovenščina (SL) (257.27 KB - PDF)
Suomi (FI) (148.01 KB - PDF)
svenska (SV) (182.78 KB - PDF)